Sigrid DaVeiga

Sigrid DaVeiga is a Board Certified Allergy/Immunology physician with an M.D. from Loyola University in Chicago. They trained in Pediatrics at St. Christopher’s Hospital for Children in Philadelphia, serving as Chief Resident, and completed their Allergy/Immunology Fellowship at the Cleveland Clinic Foundation. Sigrid was a physician at Children’s Hospital of Philadelphia for nearly a decade, where they co-founded the Pulmonology Allergy Problematic Asthma (PAPA) Clinic and led clinical quality improvement efforts. Currently, they serve as Executive Director in Allergy Development at Eli Lilly and Company, while also holding past positions in clinical development at Moderna, GSK, and Teva Pharmaceuticals. Sigrid is active in the American Academy of Allergy Asthma and Immunology and the American College of Allergy Asthma and Immunology and has contributed extensively to research and education in their field.